|
|
||
|
per-oral
gastro-intestinal nasal pulmonal buccal sublingual Trans-mucosal
drug delivery The
Task: Your drug needs stabilisation against degradation and digestion. Your drug
needs a protected and controlled transport from the site of administration to the site of systemic uptake. Your drug needs a penetration
enhancer at the epithelium. The side effects of the penetration
enhancer have to be minimized. Your drug and the penetration enhancer exhibit highly different physico-chemical
properties. The
Concept: Drug protection against
degradation and digestion by encapsulation in highly stable A-fect™
liposomes. Co-encapsulation of the penetration enhancer with your drug in A-fect™
liposomes. The penetration enhancer is co-localized
with your drug without chemical bonding. Minimised total dose of the penetration
enhancer Modified
release profile by means of A-fect™-tetraether
lipids The
Realisation: A
new generation of stable liposomes – Bernina's A-fectTM
- provides the controlled delivery
from the site of administration to the site of systemic uptake |
|
|
|
|||
|